ERBB2 and breast cancer: Moreover, we observed an association between the pattern of syndecan-1 expression and the BC intrinsic subtype of metastatic lesions, with a more diffuse pattern of immunostaining in TN and HER2 overexpressing lesions (with or without hormone receptor positivity).